Analyzing lung cancer risks in patients with impaired pulmonary function through characterization of gut microbiome and metabolites

Analyzing lung cancer risks in patients with impaired pulmonary function through characterization of gut microbiome and metabolites

Abstract Background Lung cancer (LC) is one of the most devastating diseases worldwide, there is growing studies confirm the role of impaired lung function in LC susceptibility. Moreover, gut microbiota dysbiosis is associated with LC severity. Whether alterations in gut microbiota and metabolites a...

Full description

Bibliographic Details
Main Authors: Jiahui Luan, Fuxin Zhang, Lijun Suo, Wei Zhang, Yige Li, Xiaofeng Yu, Bo Liu, Hongyun Cao
Format: Article
Language:English
Published: BMC 2024-01-01
Series:BMC Pulmonary Medicine
Subjects:
Lung cancer
Gut microbiota
Metabolomics
Pulmonary function
Biomarkers
Online Access:https://doi.org/10.1186/s12890-023-02825-6

Internet

https://doi.org/10.1186/s12890-023-02825-6

Similar Items